These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The dry powder inhaler features of the Easyhaler that benefit the management of patients. Chrystyn H; Lavorini F Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627 [No Abstract] [Full Text] [Related]
3. Consistent Dosing Through the Salmeterol-Fluticasone Propionate Easyhaler for the Management of Asthma and Chronic Obstructive Pulmonary Disease: Robustness Analysis Across the Easyhaler Lifetime. Turpeinen A; Eriksson P; Happonen A; Husman-Piirainen J; Haikarainen J J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):189-196. PubMed ID: 32960127 [No Abstract] [Full Text] [Related]
4. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases. Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J Respir Med; 2023; 219():107435. PubMed ID: 38652077 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466 [TBL] [Abstract][Full Text] [Related]
7. The ideal inhaler: design and characteristics to improve outcomes. O'Connor BJ Respir Med; 2004 Apr; 98 Suppl A():S10-6. PubMed ID: 15139563 [TBL] [Abstract][Full Text] [Related]
8. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany. Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998 [TBL] [Abstract][Full Text] [Related]
9. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler Tamási L; Szilasi M; Gálffy G Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185 [TBL] [Abstract][Full Text] [Related]
10. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [TBL] [Abstract][Full Text] [Related]
11. Demographic and Asthma-Related Characteristics of Asthmatics Using Pressurized Metered Dose Inhalers and Dry Powder Inhalers. Aksu K; Vural Solak GT; Mutlu LC; Mutlu P; Vayısoğlu Şahin G; Erdem Türe E; Yormaz B; Çapraz A; Coşkun Beyan A; Solak Y; Aksu F J Aerosol Med Pulm Drug Deliv; 2024 Dec; 37(6):346-350. PubMed ID: 39075039 [No Abstract] [Full Text] [Related]
13. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence. Aggarwal B; Gogtay J Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511 [TBL] [Abstract][Full Text] [Related]
14. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD. Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863 [TBL] [Abstract][Full Text] [Related]
15. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI. Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719 [TBL] [Abstract][Full Text] [Related]
16. Maintenance Inhalers for Asthma and COPD in Spain. Muñoz X; Giner J; Sicras A; Lo Re D Respir Care; 2024 Nov; 69(12):1534-1542. PubMed ID: 38906702 [TBL] [Abstract][Full Text] [Related]
17. Novolizer: how does it fit into inhalation therapy? Magnussen H Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944 [TBL] [Abstract][Full Text] [Related]
18. Aerosol Plumes of Inhalers Used in COPD. Wachtel H; Emerson-Stadler R; Langguth P; Hohlfeld JM; Ohar J Pulm Ther; 2024 Mar; 10(1):109-122. PubMed ID: 38194194 [TBL] [Abstract][Full Text] [Related]
19. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study. Virchow JC; Weuthen T; Harmer QJ; Jones S Expert Opin Drug Deliv; 2014 Dec; 11(12):1849-57. PubMed ID: 25151851 [TBL] [Abstract][Full Text] [Related]
20. Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer. Newman SP; Pitcairn GR; Adkin DA; Vidgren MT; Silvasti M J Aerosol Med; 2001; 14(2):217-25. PubMed ID: 11681653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]